Peptides targeting estrogen receptor alpha-potential applications for breast cancer treatment

Area of Science:

• Endocrinology
• Oncology
• Drug Discovery

Background:

• Estrogen receptor alpha (ERα) activation drives hormone-dependent breast cancer development.
• Current therapies like aromatase inhibitors and antiestrogens targeting the ligand-binding pocket often lead to tumor resistance.
• A multi-target strategy is needed to circumvent resistance by targeting ERα domains beyond the ligand-binding pocket.

Purpose of the Study:

• To identify and review functional motifs for designing novel ERα antagonists.
• To explore peptides and their mimics as potential inhibitors of intra- or inter-molecular interactions within ERα.
• To propose new therapeutic strategies for overcoming resistance in hormone-dependent breast cancers.

Main Methods:

• Review of existing literature on functional motifs for ERα antagonists.
• Analysis of peptidic and non-peptidic mimics targeting ERα regulatory domains.
• Evaluation of strategies to inhibit ERα intra- or inter-molecular interactions.

Main Results:

• Identification of specific functional motifs suitable for designing ERα antagonists.
• Review of the activity of available peptidic and non-peptidic mimics of these motifs.
• Potential for novel therapeutic agents targeting distinct ERα domains.

Conclusions:

• Targeting ERα domains beyond the ligand-binding pocket presents a promising strategy to overcome therapeutic resistance.
• Peptide-based inhibitors and their mimics show potential for developing novel anti-cancer agents.
• A multi-target approach may enhance efficacy and circumvent resistance mechanisms in breast cancer treatment.